(1 month, 1 week ago)
Commons ChamberMy hon. Friend is right that we inherited a community pharmacy system that had been neglected for far too long, such that over the past two years, on average six pharmacies have been closing every week. A wide range of community pharmacies and representative organisations fed into the public consultation on hub and spoke reform, and I am pleased to confirm that their responses were overwhelmingly positive in support of model 1 of hub and spoke, which we will be going with.
I recently visited Well pharmacy in Northallerton, which, like so many others, plays an important role in providing community health services. One valued service is the provision of free blood pressure checks to those over the age of 40. Will the Minister to join me in urging anyone with health worries or a family history of high blood pressure to take advantage of this fantastic free, pharmacy-led, preventive community health service?
The right hon. Gentleman is right that a big part of the Government’s shift from hospital to community is the pivotal role that community pharmacies will play in that process. We are committed to the Pharmacy First model of enabling community pharmacies to do more clinical work, such as the type that he just described. That is at the heart of our 10-year plan.
(3 months, 4 weeks ago)
Commons ChamberMy hon. Friend is absolutely right to describe the Isle of Wight as a dental desert. That is perhaps one of the reasons why the good people of that island elected a Labour Member for the first time in history. Our ambition is to make sure that everyone who needs a dentist can get one. Sadly, 28% of adults in England—13 million people—have an unmet need for NHS dentistry. I would be glad to meet my hon. Friend to learn more about how the experience of the Isle of Wight can improve services nationally.
Prostate cancer is the most common cancer in men, yet it has no national screening programme. We worked on this issue in government, and I thank the Secretary of State for taking an interest in this area. Will he join me in commending Prostate Cancer Research’s excellent new report and urge his team to consider the findings, not least on increasing screening of at-risk groups so that we can not just save the NHS money but, more importantly, save thousands of lives?